National Institute for Health and Care Excellence2m
NICE has recommended six times more lung cancer treatment recomendations over the past ten years than in the previous decade
Sixfold increase in NICE's lung cancer treatment recommendations over the past decade. NICE has recommended osimertinib for ...
National Institute for Health and Care Excellence2d
In consultation: Guidance and quality standards
Marstacimab for treating severe haemophilia A or severe haemophilia B in people 12 years and over [ID6342] Draft guidance Technology appraisal guidance 6 February 2025 Capivasertib with fulvestrant ...